Developing the "Healthcare CEO App" for patients with type 1 diabetes transitioning from adolescence to young adulthood: A mixed-methods study.
Yueh-Tao Chiang, Chi-Wen Chang, Hsing-Yi Yu and 7 others
PMID 36289575WHAT IT FOUND
A type 1 diabetes app for adolescents moving into adulthood was built and tested with patients.
They completed tasks and rated satisfaction adequate, but the study did not test whether it improves diabetes control.
Key findings
01Thirty-five patients with type 1 diabetes took part in the application testing process.
02Ten patients completed designated tasks during think-aloud testing.
03Twenty patients used the application for four weeks and rated user interaction satisfaction adequate, with median scores 4 to 5.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
It tested development, usability, and satisfaction, not whether the app improved blood glucose control, hypoglycaemia, time in range, or quality of life. Small testing samples: five patients in heuristic evaluation, ten in think-aloud testing, and twenty in satisfaction assessment. Single centre in northern Taiwan, Android only, and Mandarin or Taiwanese language requirement may limit generalisability. Participants were aged 16 to 25 years with type 1 diabetes, so results may not apply to younger children, older adults, or other populations. Some users found the content comprehensive but cumbersome, and the app had many functions. No randomised comparison or follow-up clinical outcome was reported.
Declared interests
Funded by the Ministry of Science and Technology and Chang Gung University. The authors declared no conflict of interest.
The easy way to misread this
Do not conclude that this app improves diabetes control. The study tested development, usability, and satisfaction only. It did not compare the app with usual care or report changes in HbA1c, time in range, hypoglycaemia, or quality of life.